Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Nov 15;89(22):11056–11058. doi: 10.1073/pnas.89.22.11056

Antithrombotic effect of beta,beta'-monochloromethylene diadenosine 5',5"'-P1,P4-tetraphosphate.

B K Kim 1, P Zamecnik 1, G Taylor 1, M J Guo 1, G M Blackburn 1
PMCID: PMC50482  PMID: 1438314

Abstract

The feasibility of using beta,beta'-monochloromethylene diadenosine 5',5"'-P1,P4-tetraphosphate (AppCHCl-ppA) as an antithrombotic agent was studied in a rabbit intracarotid cannula thrombosis model previously shown to be sensitive to antiplatelet agents. This analogue, having a P-C-P bridge in place of a P-O-P internucleoside linkage, has been found resistant to phosphodiesterase activity. Rabbits were infused with the dinucleotide at a dose of 50 mg per kg over a 2-hr period, at a controlled rate by pump. A 1-cm length of polyethylene cannula (1 mm i.d.) was tied into the carotid artery. Animals were stable under general anesthesia during the entire period of the experiment. In the control group, 16 of 20 animals formed clots, an incidence of 80%, whereas in the test animals, 6 of the 20 formed clots (30% incidence, P < 0.05). After preincubation of whole blood with 50 microM AppCHClppA at 37 degrees C for up to 3 hr, a consistent suppression of ADP-induced platelet aggregation was observed. The present study suggests that AppCHClppA may be useful as an antithrombotic agent in certain clinical situations, such as hemodialysis, arteriovenous shunts, and introduction of artificial heart valves. It may also possibly prevent extension of recent clots. The toxicity and metabolism of AppCHClppA have, however, yet to be explored.

Full text

PDF
11056

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackburn G. M., Taylor G. E., Thatcher G. R., Prescott M., McLennan A. G. Synthesis and resistance to enzymic hydrolysis of stereochemically-defined phosphonate and thiophosphate analogues of P1,P4-bis(5'-adenosyl) tetraphosphate. Nucleic Acids Res. 1987 Sep 11;15(17):6991–7004. doi: 10.1093/nar/15.17.6991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cardinal D. C., Flower R. J. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods. 1980 Feb;3(2):135–158. doi: 10.1016/0160-5402(80)90024-8. [DOI] [PubMed] [Google Scholar]
  3. Flodgaard H., Klenow H. Abundant amounts of diadenosine 5',5"'-P1,P4-tetraphosphate are present and releasable, but metabolically inactive, in human platelets. Biochem J. 1982 Dec 15;208(3):737–742. doi: 10.1042/bj2080737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Harrison M. J., Brossmer R. Inhibition of platelet aggregation and the platelet release reaction by alpha, omega diadenosine polyphosphates. FEBS Lett. 1975 Jun 1;54(1):57–60. doi: 10.1016/0014-5793(75)81067-2. [DOI] [PubMed] [Google Scholar]
  5. Louie S., Gurewich V. The antithrombotic effect of aspirin and dipyridamole in relation to prostaglandin synthesis. Thromb Res. 1983 May 15;30(4):323–335. doi: 10.1016/0049-3848(83)90224-4. [DOI] [PubMed] [Google Scholar]
  6. Louie S., Kim B. K., Zamecnik P. Diadenosine 5',5'''-P1,P4-tetraphosphate, a potential antithrombotic agent. Thromb Res. 1988 Mar 15;49(6):557–565. doi: 10.1016/0049-3848(88)90253-8. [DOI] [PubMed] [Google Scholar]
  7. Lüthje J., Ogilvie A. The presence of diadenosine 5',5'''-P1,P3-triphosphate (Ap3A) in human platelets. Biochem Biophys Res Commun. 1983 Aug 30;115(1):253–260. doi: 10.1016/0006-291x(83)90997-x. [DOI] [PubMed] [Google Scholar]
  8. McLennan A. G., Taylor G. E., Prescott M., Blackburn G. M. Recognition of beta beta'-substituted and alpha beta,alpha'beta'-disubstituted phosphonate analogues of bis(5'-adenosyl) tetraphosphate by the bis(5'-nucleosidyl)-tetraphosphate pyrophosphohydrolases from Artemia embryos and Escherichia coli. Biochemistry. 1989 May 2;28(9):3868–3875. doi: 10.1021/bi00435a036. [DOI] [PubMed] [Google Scholar]
  9. Mielke C. H. Measurement of the bleeding time. Thromb Haemost. 1984 Oct 31;52(2):210–211. [PubMed] [Google Scholar]
  10. Randerath K., Janeway C. M., Stephenson M. L., Zamecnik P. C. Isolation and characterization of dinucleoside tetra- and tri-phosphates formed in the presence of lysyl-sRNA synthetase. Biochem Biophys Res Commun. 1966 Jul 6;24(1):98–105. doi: 10.1016/0006-291x(66)90416-5. [DOI] [PubMed] [Google Scholar]
  11. Rapaport E., Zamecnik P. C. Presence of diadenosine 5',5''' -P1, P4-tetraphosphate (Ap4A) in mamalian cells in levels varying widely with proliferative activity of the tissue: a possible positive "pleiotypic activator". Proc Natl Acad Sci U S A. 1976 Nov;73(11):3984–3988. doi: 10.1073/pnas.73.11.3984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Zamecnik P. C., Kim B., Gao M. J., Taylor G., Blackburn G. M. Analogues of diadenosine 5',5'''-P1,P4-tetraphosphate (Ap4A) as potential anti-platelet-aggregation agents. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2370–2373. doi: 10.1073/pnas.89.6.2370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Zamecnik P. C., Stephenson M. L., Janeway C. M., Randerath K. Enzymatic synthesis of diadenosine tetraphosphate and diadenosine triphosphate with a purified lysyl-sRNA synthetase. Biochem Biophys Res Commun. 1966 Jul 6;24(1):91–97. doi: 10.1016/0006-291x(66)90415-3. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES